APA (7th ed.) Citation

C, P., CC, R., D, S., V, S., N, S., P, Y., . . . Z, S. (2026). Pharmacologic Management of Type 2 Myocardial Infarction: An Underdefined Frontier. Journal of cardiovascular pharmacology. https://doi.org/10.1097/FJC.0000000000001855

Chicago Style (17th ed.) Citation

C, Puchongmart, Rodriguez CC, Soliman D, Shotelersuk V, Sivakumar N, Yanpiset P, Thiravetyan B, Leelaviwat N, and Sly Z. "Pharmacologic Management of Type 2 Myocardial Infarction: An Underdefined Frontier." Journal of Cardiovascular Pharmacology 2026. https://doi.org/10.1097/FJC.0000000000001855.

MLA (9th ed.) Citation

C, Puchongmart, et al. "Pharmacologic Management of Type 2 Myocardial Infarction: An Underdefined Frontier." Journal of Cardiovascular Pharmacology, 2026, https://doi.org/10.1097/FJC.0000000000001855.